Suivre
Maureen Mealy
Maureen Mealy
Johns Hopkins University School of Medicine
Adresse e-mail validée de jhmi.edu
Titre
Citée par
Citée par
Année
Epidemiology of neuromyelitis optica in the United States: a multicenter analysis
MA Mealy, DM Wingerchuk, BM Greenberg, M Levy
Archives of neurology 69 (9), 1176-1180, 2012
3422012
Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy
MA Mealy, DM Wingerchuk, J Palace, BM Greenberg, M Levy
JAMA neurology 71 (3), 324-330, 2014
3192014
Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange
H Abboud, A Petrak, M Mealy, S Sasidharan, L Siddique, M Levy
Multiple Sclerosis Journal 22 (2), 185-192, 2016
2422016
MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder
R Narayan, A Simpson, K Fritsche, S Salama, S Pardo, M Mealy, F Paul, ...
Multiple sclerosis and related disorders 25, 66-72, 2018
2072018
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients
L Kremer, M Mealy, A Jacob, I Nakashima, P Cabre, S Bigi, F Paul, ...
Multiple Sclerosis Journal 20 (7), 843-847, 2014
1942014
Treatment of neuromyelitis optica spectrum disorder: acute, preventive, and symptomatic
RA Kessler, MA Mealy, M Levy
Current treatment options in neurology 18, 1-15, 2016
1572016
Racial differences in neuromyelitis optica spectrum disorder
SH Kim, MA Mealy, M Levy, F Schmidt, K Ruprecht, F Paul, M Ringelstein, ...
Neurology 91 (22), e2089-e2099, 2018
1492018
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica
ES Sotirchos, S Saidha, G Byraiah, MA Mealy, MA Ibrahim, YJ Sepah, ...
Neurology 80 (15), 1406-1414, 2013
1412013
Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging
Y Pekcevik, CH Mitchell, MA Mealy, G Orman, IH Lee, SD Newsome, ...
Multiple Sclerosis Journal 22 (3), 302-311, 2016
1272016
Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder
VS Chavarro, MA Mealy, A Simpson, A Lacheta, F Pache, K Ruprecht, ...
Neurology: Neuroimmunology & Neuroinflammation 3 (6), e286, 2016
1072016
Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis
MA Mealy, A Whetstone, G Orman, I Izbudak, PA Calabresi, M Levy
Journal of the neurological sciences 355 (1-2), 59-63, 2015
922015
Serum glial fibrillary acidic protein: a neuromyelitis optica spectrum disorder biomarker
O Aktas, MA Smith, WA Rees, JL Bennett, D She, E Katz, BAC Cree, ...
Annals of neurology 89 (5), 895-910, 2021
842021
Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion …
ES Sotirchos, A Filippatou, KC Fitzgerald, S Salama, S Pardo, J Wang, ...
Multiple Sclerosis Journal 26 (11), 1360-1371, 2020
842020
Clinical biomarkers differentiate myelitis from vascular and other causes of myelopathy
P Barreras, KC Fitzgerald, MA Mealy, JA Jimenez, D Becker, ...
Neurology 90 (1), e12-e21, 2018
842018
Mortality in neuromyelitis optica is strongly associated with African ancestry
MA Mealy, RA Kessler, Z Rimler, A Reid, L Totonis, G Cutter, I Kister, ...
Neurology: Neuroimmunology & Neuroinflammation 5 (4), e468, 2018
802018
Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica
M Levy, MA Mealy
Neuroimmunology & Neuroinflammation 1 (1), e5, 2014
752014
High risk of postpartum relapses in neuromyelitis optica spectrum disorder
EC Klawiter, R Bove, L Elsone, E Alvarez, N Borisow, M Cortez, F Mateen, ...
Neurology 89 (22), 2238-2244, 2017
692017
Patient perspectives on neuromyelitis optica spectrum disorders: data from the PatientsLikeMe online community
S Eaneff, V Wang, M Hanger, M Levy, MA Mealy, AU Brandt, D Eek, ...
Multiple sclerosis and related disorders 17, 116-122, 2017
542017
Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion …
MA Mealy, SE Mossburg, SH Kim, S Messina, N Borisow, ...
Multiple sclerosis and related disorders 28, 64-68, 2019
532019
Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders
MA Mealy, SH Kim, F Schmidt, R López, JA Jimenez Arango, F Paul, ...
Multiple Sclerosis Journal 24 (13), 1737-1742, 2018
522018
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20